IT1282692B1 - Citochine modificate per l'uso in terapia - Google Patents
Citochine modificate per l'uso in terapiaInfo
- Publication number
- IT1282692B1 IT1282692B1 IT96MI000358A ITMI960358A IT1282692B1 IT 1282692 B1 IT1282692 B1 IT 1282692B1 IT 96MI000358 A IT96MI000358 A IT 96MI000358A IT MI960358 A ITMI960358 A IT MI960358A IT 1282692 B1 IT1282692 B1 IT 1282692B1
- Authority
- IT
- Italy
- Prior art keywords
- therapy use
- cytokines
- modified
- cytokines modified
- therapy
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
- A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI000358A IT1282692B1 (it) | 1996-02-27 | 1996-02-27 | Citochine modificate per l'uso in terapia |
JP9530545A JP2000506835A (ja) | 1996-02-27 | 1997-02-14 | 治療用の修飾サイトカイン |
CA002247308A CA2247308A1 (en) | 1996-02-27 | 1997-02-14 | Modified cytokines for therapeutic use |
AU17694/97A AU1769497A (en) | 1996-02-27 | 1997-02-14 | Modified cytokines for therapeutic use |
EP97903285A EP0885015A2 (en) | 1996-02-27 | 1997-02-14 | Modified cytokines for therapeutic use |
PCT/EP1997/000704 WO1997031655A2 (en) | 1996-02-27 | 1997-02-14 | Modified cytokines for therapeutic use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96MI000358A IT1282692B1 (it) | 1996-02-27 | 1996-02-27 | Citochine modificate per l'uso in terapia |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI960358A0 ITMI960358A0 (it) | 1996-02-27 |
ITMI960358A1 ITMI960358A1 (it) | 1997-08-27 |
IT1282692B1 true IT1282692B1 (it) | 1998-03-31 |
Family
ID=11373397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT96MI000358A IT1282692B1 (it) | 1996-02-27 | 1996-02-27 | Citochine modificate per l'uso in terapia |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0885015A2 (it) |
JP (1) | JP2000506835A (it) |
AU (1) | AU1769497A (it) |
CA (1) | CA2247308A1 (it) |
IT (1) | IT1282692B1 (it) |
WO (1) | WO1997031655A2 (it) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000012554A1 (fr) * | 1998-08-28 | 2000-03-09 | Commissariat A L'energie Atomique | Procede de synthese d'une chimiokine marquee, chimiokine marquee et trousse d'analyse |
FR2783528A1 (fr) * | 1998-08-28 | 2000-03-24 | Commissariat Energie Atomique | Procede de synthese d'une chimiokine marquee, chimiokine marquee et trousse d'analyse |
DE19845798A1 (de) * | 1998-09-29 | 2000-04-13 | Schering Ag | Verwendung von Neoangiogenese-Markern für Diagnose und Therapie von Tumoren, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung |
EP2244738B1 (en) | 2008-01-25 | 2020-03-04 | Gavish-Galilee Bio Applications Ltd | Targeting of innate immune response to tumour site |
EA201892619A1 (ru) * | 2011-04-29 | 2019-04-30 | Роше Гликарт Аг | Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2 |
BR112016021717A2 (pt) | 2014-03-21 | 2018-07-10 | Abbvie Inc | anticorpos anti-egfr e conjugados anticorpo-fármaco |
JP2019521973A (ja) | 2016-06-08 | 2019-08-08 | アッヴィ・インコーポレイテッド | 抗bh7−h3抗体及び抗体薬物コンジュゲート |
AU2017279539A1 (en) | 2016-06-08 | 2019-01-03 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
PL3458479T3 (pl) | 2016-06-08 | 2021-07-26 | Abbvie Inc. | Przeciwciała anty-b7-h3 i koniugaty przeciwciało-lek |
JP2019524651A (ja) | 2016-06-08 | 2019-09-05 | アッヴィ・インコーポレイテッド | 抗cd98抗体及び抗体薬物コンジュゲート |
WO2018195302A1 (en) | 2017-04-19 | 2018-10-25 | Bluefin Biomedicine, Inc. | Anti-vtcn1 antibodies and antibody drug conjugates |
AR124681A1 (es) | 2021-01-20 | 2023-04-26 | Abbvie Inc | Conjugados anticuerpo-fármaco anti-egfr |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578287A (en) * | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
EP0682705A1 (en) * | 1993-02-03 | 1995-11-22 | N.V. Innogenetics S.A. | Tnf-alpha muteins and a process for preparing them |
CA2178476A1 (en) * | 1993-12-07 | 1995-06-15 | Neorx Corporation | Pretargeting methods and compounds |
-
1996
- 1996-02-27 IT IT96MI000358A patent/IT1282692B1/it active IP Right Grant
-
1997
- 1997-02-14 EP EP97903285A patent/EP0885015A2/en not_active Withdrawn
- 1997-02-14 JP JP9530545A patent/JP2000506835A/ja active Pending
- 1997-02-14 CA CA002247308A patent/CA2247308A1/en not_active Abandoned
- 1997-02-14 AU AU17694/97A patent/AU1769497A/en not_active Abandoned
- 1997-02-14 WO PCT/EP1997/000704 patent/WO1997031655A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0885015A2 (en) | 1998-12-23 |
ITMI960358A0 (it) | 1996-02-27 |
WO1997031655A3 (en) | 1997-11-13 |
JP2000506835A (ja) | 2000-06-06 |
WO1997031655A2 (en) | 1997-09-04 |
CA2247308A1 (en) | 1997-09-04 |
ITMI960358A1 (it) | 1997-08-27 |
AU1769497A (en) | 1997-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE9408609U1 (de) | Tragbare Stuhlkonstruktion | |
BR9711191A (pt) | Composto e uso do mesmo | |
ID16283A (id) | Senyawa yang berguna dibidang farmasi | |
BR9707812A (pt) | Composto composto farmacêutica e uso do composto | |
IT1282692B1 (it) | Citochine modificate per l'uso in terapia | |
BR7401412U (pt) | Estojo de uso pessoal | |
BR9709521A (pt) | "3-Cianoaril-pirazóis" | |
IT1285669B1 (it) | Elettrocatetere, in particolare per uso temporaneo | |
NO960449D0 (no) | Justerbar sköyte | |
KR980000501U (ko) | 작업용 이동 의자 | |
KR960006934U (ko) | 의자 | |
ITTO940810A0 (it) | "sedia" | |
IT235857Y1 (it) | "apparecchio stimolatore, in particolare per uso terapeutico" | |
BR9304388A (pt) | Composição terapêutica de uso nasal | |
DE29615015U1 (de) | Arbeitsstuhl | |
KR930022884U (ko) | 휴대용 의자 | |
KR960006928U (ko) | 위치변형 가능한 의자 | |
KR960009822U (ko) | 의자 | |
BR7401625U (pt) | Cadeira portátil desmontável | |
KR960019872U (ko) | 휴대용 의자 | |
KR970060504U (ko) | 자연의 기 흡수용 침대 | |
ITMI942406A0 (it) | Distanziale -dosatoore per uso oftalmico | |
ES1022118Y (es) | "servilleta para uso en odontologia" | |
IT1286981B1 (it) | Fibrolisore mio-fasciale ad uso fisioterapeutico | |
UA25712A (uk) | В"яжуче |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |